Xunteng International Trading Co Ltd_公司信息_产品

英文名称	CAS号	中文名	中文别名	分子式	分子量	EINECS号
SB 743921	940929-33-9	SB 743921; (R)-N-(3-AMINOPROPYL)-N-(1-(3-BENZYL-7-CHLORO-4-OXO-4H-CHROMEN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE HYDROCHLORIDE	N-(3-氨基丙基)-N-[(1R)-1-[7-氯-4-氧代-3-(苯基甲基)-4H-1-苯并吡喃-2-基]-2-甲基丙基]-4-甲基苯甲酰胺盐酸盐	C31H34Cl2N2O3	553.51926
rupatadine	158876-82-5	富马酸卢帕他定	8-氯-11-(1-((5-甲基吡啶-3-基)甲基)哌啶-4-基亚甲基)-6,11-二氢-5H-苯并[5,6]环庚烷并1,2-B]吡啶;卢帕他定;8-氯-6,11-二氢-11-[1-[(5-甲基-3-吡啶基)甲基]-4-哌啶亚基]-5H-苯并[5,6]环庚烷并[1,3-b]吡啶	C26H26N3Cl	415.95774	825-304-8
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, , ( ee)	1193697-61-8	R-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯	(S)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘-2,2'-环磷酸酯;(11BS)-8,9,10,11,12,13,14,15-OCTAHYDRO-4-HYDROXY-4-OXIDE-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN,98%,(99%EE);(S)-5,8'-八氢联萘酚磷酸酯;R-5,8'-八氢联萘酚膦酸酯	C20H25O4P	360
QS 11	944328-88-5	QS11	QS11;(2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-yl)methyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol;(betaS)-beta-[[9-([1,1'-Biphenyl]-4-ylmethyl)-2-[(2,3-dihydro-1H-inden-5-yl)oxy]-9H-purin-6-yl]amino]benzenepropanol;QS 11 (betaS)-beta-[[9-([1,1'-Biphenyl]-4-ylmethyl)-2-[(2,3-dihydro-1H-inden-5-yl)oxy]-9H-purin-6-yl]amino]benzenepropanol;(2S)-2-[2-(Indan-5-yloxy)-9-(1,1′-biphenyl-4-yl)methyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol hydrate;QS11 hydrate;(S)-2-((9-([1,1'-Biphenyl]-4-ylmethyl)-2-((2,3-dihydro-1H-inden-5-yl)oxy)-9H-purin-6-yl)amino)-3-phenylpropan-1-ol;Wnt Synergist, QS11 - CAS 944328-88-5 - Calbiochem	C36H33N5O2
N-Boc-2-pyrroleboronic acid	135884-31-0	1-Boc-吡咯-2-硼酸	N-叔丁氧羰基吡咯-2-硼酸;1-BOC-1H-吡咯-2-硼酸;1-TERT-BUTOXYCARBONYL-2-PYRROLYLBORONIC ACID;1-(TERT-BUTOXYCARBONYL)-1H-PYRROL-2-YLBORONIC ACID;N-BOC-2-吡咯硼酸;N-BOC-2-吡咯基-硼酸;(1-(叔-丁氧羰基)-1H-吡咯-2-基)硼酸;1-Boc-吡咯-2-硼酸;1-Boc-吡咯-2-硼酸	C9H14BNO4	211.02
Phencynonate	162220-36-2	N-甲基-3-氮杂双环[3,3,1]壬-9-基苯基环戊基羟基乙酸酯盐酸盐	N-甲基-3-氮杂双环[3,3,1]壬-9-基苯基环戊基羟基乙酸酯盐酸盐;苯环壬酯;(N-甲基-3-氮杂双环[3,1]壬-9-基苯基环戊基羟基乙酸酯盐酸	C22H32ClNO3	393.95
PHA-680632	398493-79-3	PHA-68632	CS-411;N-(2,6-二乙基苯基)-4,6-二氢-3-[[4-(4-甲基-1-哌嗪基)苯甲酰基]氨基]吡咯并[3,4-C]吡唑-5(1H)-甲酰胺;PHA-680632;PHA680632;PHA 680632	C28H35N7O2	501.62
PD 169316	152121-53-4	4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶	PD 169316>97%;CS-497;4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶	C20H13FN4O2	360.347	200-256-5
PD98059	167869-21-8	2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮	2-(2-氨基-3-甲氧苯基)色酮;PD 098,059 (2-(2-氨基-3-甲氧基苯基)-4H-1-苯吡喃-4-酮;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮,一种非ATP竞争性的MEK抑制剂;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮	C16H13NO3	267.28
PD 0325901	391210-10-9	N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺	PD 0325901; PD325901; PD-0325901;(R)-N-(2,3-二羟基丙氧基)-3,4-二氟-2-((2-氟-4-碘苯基)氨基)苯甲酰胺;"PD 0325901 N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺;N-[(2R)-2,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺	C16H14F3IN2O4	482.191	687-152-7
4-Acetylphenylboronic acid	149104-90-5	4-乙酰基苯硼酸	4-乙酰基苯硼酸,98%;4-乙酰苯硼酸(含有数量不等的酸酐);对乙酰苯基硼酸;4-乙酰苯硼酸,98%;对乙酰基苯硼酸;4-乙酰苯硼酸 5G;4-乙酰基苯硼酸-C;4-乙酰苯基硼酸	C8H9BO3	163.97	629-086-3
NVP-BEP800	847559-80-2	NVP-BEP8;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;CS-1973;VER-82576;NVP BEP800;VER82576;NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;2-氨基-4-[2,4-二氯-5-[2-(1-吡咯烷基)乙氧基]苯基]-N-乙基噻吩并[2,3-D]嘧啶-6-甲酰胺;VER-82576 (NVP-BEP800)	C21H23Cl2N5O2S	480.42
Nebivolol Hydrochloride	152520-56-4	盐酸奈必洛尔	盐酸萘必洛尔;奈必洛尔盐酸盐,一种选择性Β1拮抗剂;奈必洛尔盐酸盐;奈比洛尔盐酸盐;双[2-(6-氟苯并二氢吡喃-2-基)-3-羟基乙基]胺盐酸盐;盐酸奈必洛尔;盐酸奈必诺尔	C22H25F2NO4.HCL	441.9
N-(2-CYANOETHYL)GLYCINE	3088-42-4	N-(2-氰乙基)氨基乙酸	N-(2-氰乙基)氨基乙酸;N-(2-氰基乙基)甘氨酸;N-(2-氰乙基)甘氨酸;N-(β-氰乙基)甘氨酸;N-(2-氰乙基)甘氨酸,98%;N-(2-氰乙基)甘氨酸	C5H8N2O2	128.13	221-418-1
MLN9708	1201902-80-8	MLN978	枸橼酸艾沙佐米;埃沙佐米柠檬酸盐4-羧基-2-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]-6-氧代-1,3,2-二氧硼杂环己-4-乙酸;CS-1830;艾沙唑咪;MLN9708;MLN-9708;埃沙左米柠檬酸;艾沙佐米柠檬酸盐;MLN9708,20S蛋白酶体抑制剂	C20H23BCl2N2O9	517.12162
Metroprolol succinate	98418-47-4	琥珀酸美托洛尔	酒石酸;琥珀酸美托洛尔;琥珀酸美托洛尔;1-异丙氨基-3-[对-(2-甲氧乙基)苯氧基]-3-丙醇琥珀酸盐	2(C15H25NO3).C4H6O4	652.83	620-476-9
Methyl 4-fluoro-3-nitrobenzoate	329-59-9	4-氟-3-硝基苯甲酸甲酯	4-氟-3-硝基苯甲酸甲酯(CAS号:329-59-9);3-硝基-4-氟苯甲酸甲酯;甲基 4-氟-3-硝基苯甲酸酯;3-硝基-4-氟苯甲酸甲酯,97%;4-氟-3-硝基苯甲酸甲酯(易制爆);4-氟-3-硝基苯甲酸甲酯 25G;4-氟-3-硝基苯甲酸甲酯	C8H6FNO4	199.14
MC1568	852475-26-4	MC1568	3-[4-[3-(3-氟苯基)-3-氧代-1-丙烯基]-1-甲基-1H-吡咯-2-基]-N-羟基-2-丙烯酰胺	C17H15FN2O3	314.3110032
LY 294002 HYDROChloride	154447-36-6	LY2942/PI3K抑制剂	2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ON;LY294002;PI3K抑制剂;LY-294002;LY 294002;LY 294002 HYDROCHLORIDE;2-[4-MORPHOLINYL]-8-PHENYL-1[4H]-BENZOPYRAN-4-ONE;2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE;2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE HYDROCHLORIDE;2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE;2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮盐酸盐;LY 294002 盐酸盐;2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮;NSC 697286;SF 1101;LY 294002;LY-294002	C19H18ClNO3	343.8	1312995-182-4
Linagliptin	668270-12-0	利拉利汀	利那列汀;利拉列汀;利格列汀;利拉利汀原料药;利纳利汀;利拉利汀;利格列汀;BI1356;BI 1357	C25H28N8O2	472.54	1308068-626-2

英文名称

CAS号

中文名

中文别名

分子式

分子量

EINECS号

SB 743921

940929-33-9

SB 743921; (R)-N-(3-AMINOPROPYL)-N-(1-(3-BENZYL-7-CHLORO-4-OXO-4H-CHROMEN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE HYDROCHLORIDE

N-(3-氨基丙基)-N-[(1R)-1-[7-氯-4-氧代-3-(苯基甲基)-4H-1-苯并吡喃-2-基]-2-甲基丙基]-4-甲基苯甲酰胺盐酸盐

C31H34Cl2N2O3

553.51926

rupatadine

158876-82-5

富马酸卢帕他定

8-氯-11-(1-((5-甲基吡啶-3-基)甲基)哌啶-4-基亚甲基)-6,11-二氢-5H-苯并[5,6]环庚烷并1,2-B]吡啶;卢帕他定;8-氯-6,11-二氢-11-[1-[(5-甲基-3-吡啶基)甲基]-4-哌啶亚基]-5H-苯并[5,6]环庚烷并[1,3-b]吡啶

C26H26N3Cl

415.95774

825-304-8

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, , ( ee)

1193697-61-8

R-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯

(S)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘-2,2'-环磷酸酯;(11BS)-8,9,10,11,12,13,14,15-OCTAHYDRO-4-HYDROXY-4-OXIDE-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN,98%,(99%EE);(S)-5,8'-八氢联萘酚磷酸酯;R-5,8'-八氢联萘酚膦酸酯

C20H25O4P

360

QS 11

944328-88-5

QS11

QS11;(2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-yl)methyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol;(betaS)-beta-[[9-([1,1'-Biphenyl]-4-ylmethyl)-2-[(2,3-dihydro-1H-inden-5-yl)oxy]-9H-purin-6-yl]amino]benzenepropanol;QS 11 (betaS)-beta-[[9-([1,1'-Biphenyl]-4-ylmethyl)-2-[(2,3-dihydro-1H-inden-5-yl)oxy]-9H-purin-6-yl]amino]benzenepropanol;(2S)-2-[2-(Indan-5-yloxy)-9-(1,1′-biphenyl-4-yl)methyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol hydrate;QS11 hydrate;(S)-2-((9-([1,1'-Biphenyl]-4-ylmethyl)-2-((2,3-dihydro-1H-inden-5-yl)oxy)-9H-purin-6-yl)amino)-3-phenylpropan-1-ol;Wnt Synergist, QS11 - CAS 944328-88-5 - Calbiochem

C36H33N5O2

N-Boc-2-pyrroleboronic acid

135884-31-0

1-Boc-吡咯-2-硼酸

N-叔丁氧羰基吡咯-2-硼酸;1-BOC-1H-吡咯-2-硼酸;1-TERT-BUTOXYCARBONYL-2-PYRROLYLBORONIC ACID;1-(TERT-BUTOXYCARBONYL)-1H-PYRROL-2-YLBORONIC ACID;N-BOC-2-吡咯硼酸;N-BOC-2-吡咯基-硼酸;(1-(叔-丁氧羰基)-1H-吡咯-2-基)硼酸;1-Boc-吡咯-2-硼酸;1-Boc-吡咯-2-硼酸

C9H14BNO4

211.02

Phencynonate

162220-36-2

N-甲基-3-氮杂双环[3,3,1]壬-9-基苯基环戊基羟基乙酸酯盐酸盐

N-甲基-3-氮杂双环[3,3,1]壬-9-基苯基环戊基羟基乙酸酯盐酸盐;苯环壬酯;(N-甲基-3-氮杂双环[3,1]壬-9-基苯基环戊基羟基乙酸酯盐酸

C22H32ClNO3

393.95

PHA-680632

398493-79-3

PHA-68632

CS-411;N-(2,6-二乙基苯基)-4,6-二氢-3-[[4-(4-甲基-1-哌嗪基)苯甲酰基]氨基]吡咯并[3,4-C]吡唑-5(1H)-甲酰胺;PHA-680632;PHA680632;PHA 680632

C28H35N7O2

501.62

PD 169316

152121-53-4

4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶

PD 169316>97%;CS-497;4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶

C20H13FN4O2

360.347

200-256-5

PD98059

167869-21-8

2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮

2-(2-氨基-3-甲氧苯基)色酮;PD 098,059 (2-(2-氨基-3-甲氧基苯基)-4H-1-苯吡喃-4-酮;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮,一种非ATP竞争性的MEK抑制剂;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮

C16H13NO3

267.28

PD 0325901

391210-10-9

N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺

PD 0325901; PD325901; PD-0325901;(R)-N-(2,3-二羟基丙氧基)-3,4-二氟-2-((2-氟-4-碘苯基)氨基)苯甲酰胺;"PD 0325901 N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺;N-[(2R)-2,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺

C16H14F3IN2O4

482.191

687-152-7

4-Acetylphenylboronic acid

149104-90-5

4-乙酰基苯硼酸

4-乙酰基苯硼酸,98%;4-乙酰苯硼酸(含有数量不等的酸酐);对乙酰苯基硼酸;4-乙酰苯硼酸,98%;对乙酰基苯硼酸;4-乙酰苯硼酸 5G;4-乙酰基苯硼酸-C;4-乙酰苯基硼酸

C8H9BO3

163.97

629-086-3

NVP-BEP800

847559-80-2

NVP-BEP8;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE

NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;CS-1973;VER-82576;NVP BEP800;VER82576;NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;2-氨基-4-[2,4-二氯-5-[2-(1-吡咯烷基)乙氧基]苯基]-N-乙基噻吩并[2,3-D]嘧啶-6-甲酰胺;VER-82576 (NVP-BEP800)

C21H23Cl2N5O2S

480.42

Nebivolol Hydrochloride

152520-56-4

盐酸奈必洛尔

盐酸萘必洛尔;奈必洛尔盐酸盐,一种选择性Β1拮抗剂;奈必洛尔盐酸盐;奈比洛尔盐酸盐;双[2-(6-氟苯并二氢吡喃-2-基)-3-羟基乙基]胺盐酸盐;盐酸奈必洛尔;盐酸奈必诺尔

C22H25F2NO4.HCL

441.9

N-(2-CYANOETHYL)GLYCINE

3088-42-4

N-(2-氰乙基)氨基乙酸

N-(2-氰乙基)氨基乙酸;N-(2-氰基乙基)甘氨酸;N-(2-氰乙基)甘氨酸;N-(β-氰乙基)甘氨酸;N-(2-氰乙基)甘氨酸,98%;N-(2-氰乙基)甘氨酸

C5H8N2O2

128.13

221-418-1

MLN9708

1201902-80-8

MLN978

枸橼酸艾沙佐米;埃沙佐米柠檬酸盐4-羧基-2-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]-6-氧代-1,3,2-二氧硼杂环己-4-乙酸;CS-1830;艾沙唑咪;MLN9708;MLN-9708;埃沙左米柠檬酸;艾沙佐米柠檬酸盐;MLN9708,20S蛋白酶体抑制剂

C20H23BCl2N2O9

517.12162

Metroprolol succinate

98418-47-4

琥珀酸美托洛尔

酒石酸;琥珀酸美托洛尔;琥珀酸美托洛尔;1-异丙氨基-3-[对-(2-甲氧乙基)苯氧基]-3-丙醇琥珀酸盐

2(C15H25NO3).C4H6O4

652.83

620-476-9

Methyl 4-fluoro-3-nitrobenzoate

329-59-9

4-氟-3-硝基苯甲酸甲酯

4-氟-3-硝基苯甲酸甲酯(CAS号:329-59-9);3-硝基-4-氟苯甲酸甲酯;甲基 4-氟-3-硝基苯甲酸酯;3-硝基-4-氟苯甲酸甲酯,97%;4-氟-3-硝基苯甲酸甲酯(易制爆);4-氟-3-硝基苯甲酸甲酯 25G;4-氟-3-硝基苯甲酸甲酯

C8H6FNO4

199.14

MC1568

852475-26-4

MC1568

3-[4-[3-(3-氟苯基)-3-氧代-1-丙烯基]-1-甲基-1H-吡咯-2-基]-N-羟基-2-丙烯酰胺

C17H15FN2O3

314.3110032

LY 294002 HYDROChloride

154447-36-6

LY2942/PI3K抑制剂

2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ON;LY294002;PI3K抑制剂;LY-294002;LY 294002;LY 294002 HYDROCHLORIDE;2-[4-MORPHOLINYL]-8-PHENYL-1[4H]-BENZOPYRAN-4-ONE;2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE;2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE HYDROCHLORIDE;2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE;2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮盐酸盐;LY 294002 盐酸盐;2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮;NSC 697286;SF 1101;LY 294002;LY-294002

C19H18ClNO3

343.8

1312995-182-4

Linagliptin

668270-12-0

利拉利汀

利那列汀;利拉列汀;利格列汀;利拉利汀原料药;利纳利汀;利拉利汀;利格列汀;BI1356;BI 1357

C25H28N8O2

472.54

1308068-626-2